Pembrolizumab (Keytruda®) for the treatment of malignant pleural mesothelioma

Riegelnegg, M. and Rothschedl, E. (2025): Pembrolizumab (Keytruda®) for the treatment of malignant pleural mesothelioma. Fact Sheet Nr. 202.

Preview

PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
541kB

Item Type:	Horizon Scanning of Medicines
Subjects:	QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology QZ Pathology > QZ 200-380 Neoplasms.Cysts WB Practice of medicine > WB 300-962 Therapeutics WF Respiratory system
Language:	English
Series Name:	Fact Sheet Nr. 202
Deposited on:	13 Nov 2025 17:36
Last Modified:	13 Nov 2025 17:36

Repository Staff Only: item control page